Fake Advertising…

Thursday, November 2, 2017
Jeff Giampalmi
“We are pounded with hundreds of digital advertising messages daily and have become immune to their core messages”

Is digital marketing/advertising delivering on its promises?

Digital marketing promised to “revolutionize” the way businesses reached consumers. It was supposed to deliver advertising directly to the subset of consumers most likely to buy a company’s products or services. This targeted advertising promised to grow profit margins for all those who deployed and drive those who didn’t out of business. This medium seemed compelling.

From Atoms to Bits

Thursday, October 19, 2017
Jeff Giampalmi
The way we learn is changing from memorizing linear facts to “remixing” knowledge into new and innovative patterns.

Inspired by “From atoms to ‘bits’: The trend shifting the human mind toward creativity and innovation” by Doug Grunther for Trends Journal

Artificial intelligence (AI) is no longer simply a fixture in popular fiction and scientific speculation. From the very near prospect of driverless cars to “smart” homes, our relationship to artificial intelligent systems begs the inevitable question, ‘Where do we end and they begin?’ An early illustration of the role that these systems would come to play in our everyday life is when Kevin Kelly, executive editor of Wired Magazine, attended a party in 2002 thrown by Larry Page, the co-founder of Google.

S Phase using data and technology to improve biopharmaceutical company decision-making

Wednesday, August 23, 2017
Jeff Giampalmi

ATLANTA, Aug. 22, 2017 /PRNewswire/ -- In the first half of 2017, S Phase, a strategic marketing and medical communications agency focused on promotional initiatives, such as peer-to-peer programming, brand strategy, and business intelligence (BI), participated in a national speakers bureau conference and introduced several new innovative products to extend its lead as a provider of best-in-class BI solutions for the biopharmaceutical industry.

Recently, for a distinguished audience of professionals working in the biopharmaceutical and life sciences industries, S Phase was invited to present its world-class BI solutions that impact marketing, compliance, sales operations, and analytics. Blake Walter, Associate Director of Analytics, introduced attendees to S Phase's proprietary cloud-based SaaS analytics platform.

"Currently, data sets from biopharmaceutical companies and other sources reside separately in different locations within the ecosystem," explained Blake Walter, "and S ...

S Phase Completes Multiple Pharmaceutical Company CRM Integrations in 2016

Tuesday, January 31, 2017
Jeff Giampalmi

Atlanta, January 25, 2017
S Phase, an Atlanta-based company focusing exclusively on providing strategic and logistical speakers bureau and peer-to-peer programming for biopharmaceutical companies, continues to accrue unparalleled expertise in data integration and exchange, including multiple CRM integrations for a number of the world's leading biopharmaceutical companies.
"We're watching our customer's ecosystems evolve," said Deborah Prince, President of S Phase, "and it's clear that accurate, robust, and sophisticated data integration support has become a core requirement. Naturally, S Phase is evolving toowith enhanced services and amplified technology platformto ensure the highest quality solutions for all our clients."
For one such client, S Phase launched a series of parallel integrations, one connecting with the Veeva Systems CRM platform and another leveraging IMS Health's Nexxus™ platform. &ldq ...

S Phase Expands SaaS Mobile Analytics, Compliance and Meeting Management Solutions

Tuesday, September 13, 2016
Jeff Giampalmi

S Phase, an Atlanta-based leader in strategic medical communication services for biopharmaceutical clients, today unveiled a suite of SaaS mobile apps that set new standards of excellence for business intelligence, compliance and meeting management. These tools simplify the upstream portion of data management and seamlessly connect to a cloud-based data warehouse for instantaneous downstream reporting even on mobile devices.

"The launch of these three best-in-class solutions demonstrates our commitment to a mobility-first approach and to remaining leaders in providing medical educational programming to biopharmaceutical companies," said Deborah Prince, Chief Commercial Officer and President of Speaker Bureau Programming.